Wellberg et al. [40], on the other hand, showed that GLUT1 expression was higher in ductal carcinoma in situ compared to normal breast tissue but lower in invasive versus in situ lesions, suggesting that the requirement for GLUT1 was predominant in early cancer lesions but decreased with tumor progression [40]. This evidence concerns the gene SLC2A1 and cancer.